Highly potent activation of Nrf2 by topical tricyclic bis(cyano enone): Implications for protection against UV radiation during thiopurine therapy

Sukirti Kalra, Elena V. Knatko, Ying Zhang, Tadashi Honda, Masayuki Yamamoto, Albena T. Dinkova-Kostova

Research output: Contribution to journalArticle

Abstract

Chronic treatment with azathioprine, a highly effective anti-inflammatory and immunosuppressive agent, profoundly increases the risk for development of unusually aggressive cutaneous squamous cell carcinoma. Its ultimate metabolite, 6-thioguanine (6-TG) nucleotide, is incorporated in DNA of skin cells, and upon exposure to UVA radiation, causes oxidative stress, followed by damage of DNA and associated proteins. The acetylenic tricyclic bis(cyano enone) TBE-31 is a strong inhibitor of inflammation and a potent inducer of the Keap1/Nrf2/ARE pathway, which orchestrates the expression of a large network of cytoprotective genes. We now report that long-term (five days per week for four weeks) topical daily applications of small (200 nmol) quantities of TBE-31 cause a robust systemic induction of the Keap1/Nrf2/ARE pathway and decreases the 6-TG incorporation in DNA of skin, blood, and liver of azathioprine-treated mice, indicating extraordinary bioavailability and efficacy. In addition, TBE-31, at nanomolar concentrations, protects cells with 6-TG in their genomic DNA against oxidative stress caused by UVA radiation through induction of the Keap1/Nrf2/ARE pathway. At the same 6-TG DNA levels, Keap1-knockout cells, in which the pathway is constitutively upregulated, are highly resistant to UVA radiation-induced oxidative stress. The protective effects of both the Keap1-knockout genotype and TBE-31 are completely lost in the absence of transcription factor Nrf2. Our findings suggest that compounds of this kind are excellent candidates for mechanism-based chemoprotective agents against conditions in which oxidative stress and inflammation underlie disease pathogenesis. Moreover, their potential skin patch incorporation for transdermal delivery is an exciting possibility.

Original languageEnglish (US)
Pages (from-to)973-981
Number of pages9
JournalCancer Prevention Research
Volume5
Issue number7
DOIs
StatePublished - Jul 2012

Fingerprint

Thioguanine
Oxidative Stress
Radiation
Skin
DNA
Azathioprine
Transdermal Patch
Inflammation
Gene Regulatory Networks
Therapeutics
Immunosuppressive Agents
Biological Availability
DNA Damage
Squamous Cell Carcinoma
Anti-Inflammatory Agents
Transcription Factors
Genotype
TBE 31
Liver
Proteins

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Highly potent activation of Nrf2 by topical tricyclic bis(cyano enone) : Implications for protection against UV radiation during thiopurine therapy. / Kalra, Sukirti; Knatko, Elena V.; Zhang, Ying; Honda, Tadashi; Yamamoto, Masayuki; Dinkova-Kostova, Albena T.

In: Cancer Prevention Research, Vol. 5, No. 7, 07.2012, p. 973-981.

Research output: Contribution to journalArticle

Kalra, Sukirti ; Knatko, Elena V. ; Zhang, Ying ; Honda, Tadashi ; Yamamoto, Masayuki ; Dinkova-Kostova, Albena T. / Highly potent activation of Nrf2 by topical tricyclic bis(cyano enone) : Implications for protection against UV radiation during thiopurine therapy. In: Cancer Prevention Research. 2012 ; Vol. 5, No. 7. pp. 973-981.
@article{d9fe1513e58e47618038f7f6bd3e05bd,
title = "Highly potent activation of Nrf2 by topical tricyclic bis(cyano enone): Implications for protection against UV radiation during thiopurine therapy",
abstract = "Chronic treatment with azathioprine, a highly effective anti-inflammatory and immunosuppressive agent, profoundly increases the risk for development of unusually aggressive cutaneous squamous cell carcinoma. Its ultimate metabolite, 6-thioguanine (6-TG) nucleotide, is incorporated in DNA of skin cells, and upon exposure to UVA radiation, causes oxidative stress, followed by damage of DNA and associated proteins. The acetylenic tricyclic bis(cyano enone) TBE-31 is a strong inhibitor of inflammation and a potent inducer of the Keap1/Nrf2/ARE pathway, which orchestrates the expression of a large network of cytoprotective genes. We now report that long-term (five days per week for four weeks) topical daily applications of small (200 nmol) quantities of TBE-31 cause a robust systemic induction of the Keap1/Nrf2/ARE pathway and decreases the 6-TG incorporation in DNA of skin, blood, and liver of azathioprine-treated mice, indicating extraordinary bioavailability and efficacy. In addition, TBE-31, at nanomolar concentrations, protects cells with 6-TG in their genomic DNA against oxidative stress caused by UVA radiation through induction of the Keap1/Nrf2/ARE pathway. At the same 6-TG DNA levels, Keap1-knockout cells, in which the pathway is constitutively upregulated, are highly resistant to UVA radiation-induced oxidative stress. The protective effects of both the Keap1-knockout genotype and TBE-31 are completely lost in the absence of transcription factor Nrf2. Our findings suggest that compounds of this kind are excellent candidates for mechanism-based chemoprotective agents against conditions in which oxidative stress and inflammation underlie disease pathogenesis. Moreover, their potential skin patch incorporation for transdermal delivery is an exciting possibility.",
author = "Sukirti Kalra and Knatko, {Elena V.} and Ying Zhang and Tadashi Honda and Masayuki Yamamoto and Dinkova-Kostova, {Albena T.}",
year = "2012",
month = "7",
doi = "10.1158/1940-6207.CAPR-12-0041",
language = "English (US)",
volume = "5",
pages = "973--981",
journal = "Cancer Prevention Research",
issn = "1940-6207",
publisher = "American Association for Cancer Research Inc.",
number = "7",

}

TY - JOUR

T1 - Highly potent activation of Nrf2 by topical tricyclic bis(cyano enone)

T2 - Implications for protection against UV radiation during thiopurine therapy

AU - Kalra, Sukirti

AU - Knatko, Elena V.

AU - Zhang, Ying

AU - Honda, Tadashi

AU - Yamamoto, Masayuki

AU - Dinkova-Kostova, Albena T.

PY - 2012/7

Y1 - 2012/7

N2 - Chronic treatment with azathioprine, a highly effective anti-inflammatory and immunosuppressive agent, profoundly increases the risk for development of unusually aggressive cutaneous squamous cell carcinoma. Its ultimate metabolite, 6-thioguanine (6-TG) nucleotide, is incorporated in DNA of skin cells, and upon exposure to UVA radiation, causes oxidative stress, followed by damage of DNA and associated proteins. The acetylenic tricyclic bis(cyano enone) TBE-31 is a strong inhibitor of inflammation and a potent inducer of the Keap1/Nrf2/ARE pathway, which orchestrates the expression of a large network of cytoprotective genes. We now report that long-term (five days per week for four weeks) topical daily applications of small (200 nmol) quantities of TBE-31 cause a robust systemic induction of the Keap1/Nrf2/ARE pathway and decreases the 6-TG incorporation in DNA of skin, blood, and liver of azathioprine-treated mice, indicating extraordinary bioavailability and efficacy. In addition, TBE-31, at nanomolar concentrations, protects cells with 6-TG in their genomic DNA against oxidative stress caused by UVA radiation through induction of the Keap1/Nrf2/ARE pathway. At the same 6-TG DNA levels, Keap1-knockout cells, in which the pathway is constitutively upregulated, are highly resistant to UVA radiation-induced oxidative stress. The protective effects of both the Keap1-knockout genotype and TBE-31 are completely lost in the absence of transcription factor Nrf2. Our findings suggest that compounds of this kind are excellent candidates for mechanism-based chemoprotective agents against conditions in which oxidative stress and inflammation underlie disease pathogenesis. Moreover, their potential skin patch incorporation for transdermal delivery is an exciting possibility.

AB - Chronic treatment with azathioprine, a highly effective anti-inflammatory and immunosuppressive agent, profoundly increases the risk for development of unusually aggressive cutaneous squamous cell carcinoma. Its ultimate metabolite, 6-thioguanine (6-TG) nucleotide, is incorporated in DNA of skin cells, and upon exposure to UVA radiation, causes oxidative stress, followed by damage of DNA and associated proteins. The acetylenic tricyclic bis(cyano enone) TBE-31 is a strong inhibitor of inflammation and a potent inducer of the Keap1/Nrf2/ARE pathway, which orchestrates the expression of a large network of cytoprotective genes. We now report that long-term (five days per week for four weeks) topical daily applications of small (200 nmol) quantities of TBE-31 cause a robust systemic induction of the Keap1/Nrf2/ARE pathway and decreases the 6-TG incorporation in DNA of skin, blood, and liver of azathioprine-treated mice, indicating extraordinary bioavailability and efficacy. In addition, TBE-31, at nanomolar concentrations, protects cells with 6-TG in their genomic DNA against oxidative stress caused by UVA radiation through induction of the Keap1/Nrf2/ARE pathway. At the same 6-TG DNA levels, Keap1-knockout cells, in which the pathway is constitutively upregulated, are highly resistant to UVA radiation-induced oxidative stress. The protective effects of both the Keap1-knockout genotype and TBE-31 are completely lost in the absence of transcription factor Nrf2. Our findings suggest that compounds of this kind are excellent candidates for mechanism-based chemoprotective agents against conditions in which oxidative stress and inflammation underlie disease pathogenesis. Moreover, their potential skin patch incorporation for transdermal delivery is an exciting possibility.

UR - http://www.scopus.com/inward/record.url?scp=84866445766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866445766&partnerID=8YFLogxK

U2 - 10.1158/1940-6207.CAPR-12-0041

DO - 10.1158/1940-6207.CAPR-12-0041

M3 - Article

C2 - 22659146

AN - SCOPUS:84866445766

VL - 5

SP - 973

EP - 981

JO - Cancer Prevention Research

JF - Cancer Prevention Research

SN - 1940-6207

IS - 7

ER -